Clinical, Innovative, & Basic Research
Clinical, Innovative, & Basic Research
July 2024: Is protein expression in skin cells (fibroblasts) a possible biomarker in SMA?
Biomarkers are medical indicators that can be measured to show the severity, progression and response to treatment of a condition. A recent study led by Professor Heidi Fuller at Keele University looked at the levels of different proteins found in skin cells (fibroblasts) taken from people with varying severities of SMA.
Read more >
Report from the 4th International Scientific Congress on SMA
Our Scientific Research Correspondent Dr James Sleigh summarises some of the major findings presented at the 4th International Scientific Congress on SMA, organised by SMA Europe and held in Ghent, Belgium from 14th-16th March 2024. Over 1,000 scientists, clinicians and pharmaceutical company experts discussed diverse SMA-related topics covering recent laboratory-based work and clinical trial updates.
Read more >
New Research Findings – The Amino Acid Diet (Webinar, Dec 2022)
Dr Graeme O’Connor (Research Lead for Dietetics at Great Ormond St Hospital) discusses the results of a recent pilot project, and the implications this may have for others, with Michaela Hollywood (a community member who has SMA Type 2).
Read more>